Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.

@article{Oshiro2017AnalysisOR,
  title={Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.},
  author={Y. Oshiro and M. Mizumoto and T. Okumura and Kuniaki Fukuda and N. Fukumitsu and M. Abei and H. Ishikawa and D. Takizawa and H. Sakurai},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2017},
  volume={123 2},
  pages={
          240-245
        }
}
  • Y. Oshiro, M. Mizumoto, +6 authors H. Sakurai
  • Published 2017
  • Medicine
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
PURPOSE To evaluate the feasibility and efficacy of repeated proton beam therapy (PBT) and to analyze the dose-volume relationship. PATIENTS AND METHODS A retrospective analysis was performed in 83 patients who received definitive repeated PBT. Proton beams were delivered with expiratory gating. The numbers of treatment courses were 2, 3, and 4 in 68, 12, and 3 patients, respectively. MIM software was used for dose analysis. RESULTS The planned median total dose was 70.5 GyE for all tumors… Expand
Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
TLDR
Two-fraction CIRT was a well-tolerated and effective treatment for patients with HCC and no other grade 3 or higher toxicities were observed in any organ. Expand
Proton beam therapy for hepatocellular carcinoma
TLDR
The clinical rationale for using PBT for HCC patients and clinical outcome and toxicity data from retrospective and prospective studies are reviewed, and PBT-specific technical challenges for these tumors and appropriate selection of patients to be treated with PBT are discussed. Expand
Proton beam therapy for renal pelvis and ureter cancer: A report of 5 cases and a literature review
TLDR
Proton beam therapy appears to be a potential option for patients with renal pelvis or ureter cancer, especially for those who are unsuitable for radical surgery, according to limited data. Expand
Systematic Review of Radiation-Based Therapies for Hepatocellular Carcinoma
Aim Despite the increasing trend to utilize radiation therapies for the treatment of hepatocellular carcinoma (HCC), there is limited analysis comparing treatment outcomes of variousExpand
Proton beam therapy for cancer in the era of precision medicine
TLDR
This work systematically review the latest advances of PBT and the challenges for patient treatment in the era of precision medicine and provides a dosimetric advantage over photon beam therapy. Expand
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.
TLDR
Liver reirradiation may be an effective and safe option for select patients; however, further prospective study is necessary to establish treatment guidelines and recommended dosing. Expand
Three cases of hepatocellular carcinoma treated 4 times with proton beams
TLDR
The presented cases indicated that repeated PBT is an effective treatment option for recurrent HCC due to reduced liver damage and superior local treatment compared with other treatment options such as transarterial chemoembolization. Expand
Proton beam re-irradiation for gastrointestinal malignancies: a systematic review.
TLDR
Based upon the published experiences, proton-beam re-irradiation for recurrent or second primary GI cancers appears effective for palliation, with good disease-control, limited toxicity, favorable dosimetry, and overall compares well with published non-proton- beam experiences. Expand
Proton beam therapy reirradiation for breast cancer: Multi‐institutional prospective PCG registry analysis
TLDR
PBT reRT is well tolerated with favorable local control, and BMI > 30, bilateral disease, and IMN reRT were associated with grade 3 AEs, and Toxicity was acceptable despite median cumulative dose > 110 Gy. Expand
Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
TLDR
Proton beam therapy (PBT) has several unique physical properties that give it a finite range in a distal direction, and thus no exit dose along the beam path, and therefore has dosimetric advantages compared with X-ray therapy for the treatment of HCC. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 29 REFERENCES
Repeated proton beam therapy for hepatocellular carcinoma.
TLDR
Repeated proton beam therapy for HCC is safe when the patient has a target in the peripheral region of the liver and liver function is Child-Pugh class A. Expand
Proton beam therapy for large hepatocellular carcinoma.
TLDR
This study shows that PBT is an effective and safe method for the treatment of patients with large HCC because the Bragg peak properties of PBT allow for improved conformality of the treatment field. Expand
Proton beam therapy for aged patients with hepatocellular carcinoma.
TLDR
Proton beam therapy seems to be tolerable, effective, and safe for aged patients with HCC, and may contribute to prolonged survival due to tumor control. Expand
Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols.
TLDR
This study showed that proton beam therapy achieved good local control for HCC using each of three treatment protocols, suggesting that selection of treatment schedules based on tumor location may be used to reduce the risk of late toxicity and maintain good treatment efficacy. Expand
A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma.
TLDR
Hypofractionated proton beam therapy is safe and well-tolerated by patients with HCC located greater than 2 cm away from the porta hepatis or gastrointestinal tract and may be effective alternative to other modalities. Expand
Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.
TLDR
The PBT delivering 72.6 GyE in 22 fractions appears to be effective and safe for HCC adjacent to the porta hepatis and no late treatment-related toxicity of Grade 2 or higher was observed. Expand
Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract.
TLDR
The authors' proton beam therapy strategy for HCC located adjacent to the alimentary tract seems to be effective but should be performed with caution. Expand
Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma.
  • A. Huertas, A. Baumann, +7 authors D. Peiffert
  • Medicine
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2015
TLDR
SBRT allows high local control for inoperable hepatocellular carcinomas and should be considered when an ablative treatment is indicated in Child A patients. Expand
Proton-Beam Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis*
TLDR
PBT improved local control and significantly prolonged survival in HCC patients with PVTT in the setting of HCC in a retrospective review to evaluate the efficacy of proton-beam therapy (PBT) for patients presenting with PV TT. Expand
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
TLDR
Biologically potent doses of SBRT are well tolerated in patients with limited liver metastases, and form the basis for an ongoing Phase II S BRT study of 60 Gy over three fractions for liver metastased patients. Expand
...
1
2
3
...